BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 13860781)

  • 21. Trifluoperazine combined with chlorpromazine.
    BARSA JA; SAUNDERS JC
    Am J Psychiatry; 1960 Apr; 116():925. PubMed ID: 13797144
    [No Abstract]   [Full Text] [Related]  

  • 22. [A case of compulsion neurosis greatly improved by ascorbic acid].
    REIFENBERG E
    Psychiatr Neurol Med Psychol (Leipz); 1953 Apr; 5(4):161-7. PubMed ID: 13074423
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of obsessive-compulsive disorder.
    Veale D
    Br J Hosp Med; 1990 Apr; 43(4):278-81. PubMed ID: 2189520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of butyrylperazine and trifluoperazine in chronic schizophrenic subjects.
    MANDEL W; EVANS P
    Am J Psychiatry; 1962 Jul; 119():70-1. PubMed ID: 14469191
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical evaluation of trifluoperazine].
    LEGER Y; BERTHIAUME M; FERRON LP; PAUL-HUS G; LEGAULT R; BISSON F
    Can Psychiatr Assoc J; 1959 Oct; 4():239-42. PubMed ID: 14415313
    [No Abstract]   [Full Text] [Related]  

  • 26. A CONTROLLED TRIAL WITH 'VALIUM' IN OBSESSIVE COMPULSIVE STATE.
    VENKOBARAO A
    J Indian Med Assoc; 1964 Jun; 42():564-7. PubMed ID: 14169176
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of trifluoperazine on auditory hallucinations in schizophrenics].
    KRUSE W
    Nervenarzt; 1960 Apr; 31():180-2. PubMed ID: 14412286
    [No Abstract]   [Full Text] [Related]  

  • 28. [Neuroses and their treatment].
    Volmat R
    Rev Med Liege; 1972 Apr; 27(8):241-7. PubMed ID: 5014987
    [No Abstract]   [Full Text] [Related]  

  • 29. Trifluoperazine and Tranylcypromine in chronic refractory schizophrenics.
    KRUSE W
    Am J Psychiatry; 1960 Dec; 117():548-9. PubMed ID: 13754637
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of fluphenazine, trifluoperazine and a placebo in the context of an active treatment unit.
    HOWELL RJ; BROWN HM; BEAGHLER HE
    J Nerv Ment Dis; 1961 Jun; 132():522-30. PubMed ID: 13716275
    [No Abstract]   [Full Text] [Related]  

  • 31. Response to trifluoperazine and chlorpromazine, singly and in combination, in chronic, "backward" patients.
    TERRELL MS
    Dis Nerv Syst; 1962 Jan; 23():41-8. PubMed ID: 13920357
    [No Abstract]   [Full Text] [Related]  

  • 32. A clinical trial of 'stelazine' in the treatment of chronic schizophrenia.
    BATT JC
    Postgrad Med J; 1959 Oct; 35(408):571-4. PubMed ID: 13797534
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of results in schizophrenics treated with (1) insulin, (2) trifluoperazine ("Stelazine").
    MCNEILL DL; MADGWICK JR
    J Ment Sci; 1961 Mar; 107():297-9. PubMed ID: 13774153
    [No Abstract]   [Full Text] [Related]  

  • 34. Some observations on obsessive-compulsive behavior.
    ROTH N
    Am J Psychother; 1952 Jan; 6(1):7-22. PubMed ID: 14894716
    [No Abstract]   [Full Text] [Related]  

  • 35. [CLINICAL TRIAL OF A NEW TRANQUILIZER, A BENZODIAZEPINE SERIES DERIVATIVE: RO 5-2807].
    DEBERDT R
    Acta Neurol Psychiatr Belg; 1964 Apr; 64():356-9. PubMed ID: 14176010
    [No Abstract]   [Full Text] [Related]  

  • 36. A double-blind trial to investigate the effects of Thorazine (Largactil, chlorpromazine), Compazine (Stemetil, prochlorperazine) and Stelazine (trifluoperazine) in paranoid schizophrenia.
    WILSON IC; McKAY J; SANDIFER MG
    J Ment Sci; 1961 Jan; 107():90-9. PubMed ID: 13785665
    [No Abstract]   [Full Text] [Related]  

  • 37. [USE OF OXYLIDINE IN THE AMBULATORY TREATMENT OF MENTAL PATIENTS].
    LEVIT VG; SMULEVICH AB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1963; 63():1541-5. PubMed ID: 14183985
    [No Abstract]   [Full Text] [Related]  

  • 38. [A NEW ANXIOLYTIC AGENT: RO 5-2807 OR DIAZEPAM].
    COLLARD J; KERF J
    Acta Neurol Psychiatr Belg; 1963 Dec; 63():1004-10. PubMed ID: 14106845
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of stelazine and parnate in chronic, withdrawn patients.
    VOGT AH
    Am J Psychiatry; 1961 Sep; 118():256-7. PubMed ID: 13781857
    [No Abstract]   [Full Text] [Related]  

  • 40. THREE EVALUATIONS OF A MONOAMINE OXIDASE INHIBITOR AND PHENOTHIAZINE COMBINATION (A METHODOLOGICAL AND CLINICAL STUDY).
    WINKELMANN W
    Dis Nerv Syst; 1965 Mar; 26():160-4. PubMed ID: 14262229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.